1,25-(OH)2-vitamin D3 prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4-/- model

Biochemical and Biophysical Research Communications

Volumn 459, Issue 2, 2015, Pages 227-233

  Reiter, Florian P ^a   Hohenester, Simon ^a   Nagel, Jutta M ^a   Wimmer, Ralf ^a   Artmann, Renate ^a   Wottke, Lena ^a   Makeschin, Marie Christine ^a   Mayr, Doris ^a   Rust, Christian ^b   Trauner, Michael ^c   Denk, Gerald U ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b KRANKENHAUS BARMHERZIGE BRÜDER   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Abcb4; Calcitriol; Cholestasis; Fibrosis; Primary sclerosing cholangitis; Vitamin D

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; BILIRUBIN; CALCITRIOL; CD11B ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; COLLAGENASE 3; HYDROXYPROLINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 3; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; IMMUNOLOGIC FACTOR; MMP13 PROTEIN, MOUSE; MULTIDRUG RESISTANCE PROTEIN; P-GLYCOPROTEIN 2;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER INJURY; LIVER PROTECTION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STELLATE CELL; TREATMENT DURATION; ZYMOGRAPHY; ANIMAL; CELL CULTURE; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETICS; HEPATITIS, ANIMAL; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

ANIMALS; CALCITRIOL; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HEPATIC STELLATE CELLS; HEPATITIS, ANIMAL; IMMUNOLOGIC FACTORS; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 13; MICE; MICE, KNOCKOUT; P-GLYCOPROTEINS; RNA, MESSENGER;

EID: 84925500322     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.02.074     Document Type: Article

References (32)

1. J.M. Farrant, K.M. Hayllar, and M.L. Wilkinson Natural history and prognostic variables in primary sclerosing cholangitis Gastroenterology 100 6 1991 1710 1717
2. R. Chapman, J. Fevery, and A. Kalloo Diagnosis and management of primary sclerosing cholangitis Hepatology 51 2 2010 660 678
3. S.L. Friedman Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury J. Biol. Chem. 275 4 2000 2247 2250
4. S. Abramovitch, L. Dahan-Bachar, and E. Sharvit Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats Gut 60 12 2011 1728 1737
5. N. Ding, R.T. Yu, and N. Subramaniam A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response Cell 153 3 2013 601 613
6. J. Arteh, S. Narra, and S. Nair Prevalence of vitamin D deficiency in chronic liver disease Dig. Dis. Sci. 55 9 2010 2624 2628
7. S. Petta, C. Cammà, and C. Scazzone Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C Hepatology 51 4 2010 1158 1167
8. J. Dasarathy, P. Periyalwar, and S. Allampati Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease Liver Int. 34 6 2014 e118 e127
9. C. Efe, T. Kav, and C. Aydin Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis Dig. Dis. Sci. 59 12 2014 3035 3042
10. F. Finkelmeier, B. Kronenberger, and V. Köberle Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study Aliment. Pharmacol. Ther. 39 10 2014 1204 1212
11. D.S. Smyk, T. Orfanidou, and P. Invernizzi Vitamin D in autoimmune liver disease Clin. Res. Hepatol. Gastroenterol. 37 5 2013 535 545
12. B.J. Song, and D.C. Rockey Status of research on vitamin D supplementation in treating or preventing liver fibrosis Liver Int. 33 5 2013 653 655
13. L.Y. Lim, and N. Chalasani Vitamin d deficiency in patients with chronic liver disease and cirrhosis Curr. Gastroenterol. Rep. 14 1 2012 67 73
14. Y. Popov, E. Patsenker, and P. Fickert Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes J. Hepatol. 43 6 2005 1045 1054
15. P. Fickert, A. Fuchsbichler, and M. Wagner Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice Gastroenterology 127 1 2004 261 274
16. T.H. Mauad, C.M. van Nieuwkerk, and K.P. Dingemans Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis Am. J. Pathol. 145 5 1994 1237 1245
17. S.L. Friedman, and F.J. Roll Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan Anal. Biochem. 161 1 1987 207 218
18. P. Fickert, M. Wagner, and H.U. Marschall 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice Gastroenterology 130 2 2006 465 481
19. C.A. Edwards, and W.D. O'Brien Jr. Modified assay for determination of hydroxyproline in a tissue hydrolyzate Clin. Chim. Acta 104 2 1980 161 167
20. K. Hochrath, C.S. Stokes, and J. Geisel Vitamin D modulates biliary fibrosis in ABCB4-deficient mice Hepatol. Int. 8 3 2014 443 452
21. S. Abramovitch, E. Sharvit, and Y. Weisman Vitamin D inhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosis Am. J. Physiol. Gastrointest. Liver Physiol. 308 2 2015 Jan 15 G112 G120 10.1152/ajpgi.00132.2013 Epub 2014 Sep. 11
22. J.P. Iredale, R.C. Benyon, and J. Pickering Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors J. Clin. Invest 102 3 1998 538 549
23. A. Beilfuss, J.P. Sowa, and S. Sydor Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently Gut. 2014 Aug 18 http://dx.doi.org/110.1136/gutjnl-2014-307024 pii: gutjnl-2014-307024. (Epub ahead of print)
24. T. Watanabe, M. Niioka, and S. Hozawa Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride J. Hepatol. 33 2 2000 224 235
25. E.J. Kim, H.J. Cho, and D. Park Antifibrotic effect of MMP13-encoding plasmid DNA delivered using polyethylenimine shielded with hyaluronic acid Mol. Ther. 19 2 2011 355 361
26. Y. Ishida, T. Kondo, and K. Tsuneyama The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice J. Leukoc. Biol. 75 1 2004 59 67
27. K. Sudo, Y. Yamada, and H. Moriwaki Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice Cytokine 29 5 2005 236 244
28. M.R. Haussler, L.A. Nagode, and H. Rasmussen Induction of intestinal brush border alkaline phosphatase by vitamin D and identity with ca-ATPase Nature 228 5277 1970 1199 1201
29. K. Poelstra, W.W. Bakker, and P.A. Klok A physiologic function for alkaline phosphatase: endotoxin detoxification Lab. Invest 76 3 1997 319 327
30. R. Neeman, S. Abramovitch, and E. Sharvit Vitamin D and S-farnesylthiosalicylic acid have a synergistic effect on hepatic stellate cell proliferation Dig. Dis. Sci. 59 10 2014 2462 2469
31. C.J. Rosen, J.S. Adams, and D.D. Bikle The nonskeletal effects of vitamin D: an endocrine Society scientific statement Endocr. Rev. 33 3 2012 456 492
32. I.A. Nakchbandi Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications World J. Gastroenterol. 20 28 2014 9427 9438